Galectin Therapeutics Inc (GALT) stock
GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.69−0.12 (-4.27%)
Close on Nov 20, 2026Market cap $271.29MP/E –Yield –
Galectin Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2015 it was -$16.98M. The highest annual figure on record is -$5.68M in fiscal 2011.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | -$16.98M | – |
| FY2014 | Dec 31, 2014 | -$12.43M | – |
| FY2013 | Dec 31, 2013 | -$7.48M | – |
| FY2012 | Dec 31, 2012 | -$7.51M | – |
| FY2011 | Dec 31, 2011 | -$5.68M | – |
See a number that looks wrong?